Table 3.
Comorbidities and underlying conditions among patients with coronavirus disease 2019.
| Characteristic | All cases | Non-severe cases (asymptomatic and mild/moderate) | Severe cases (severe and critical) | P-value |
|---|---|---|---|---|
| i = 2617 | n = 2503 | n = 114 | ||
| At least one comorbidity, n (%) | 285 (10.9) | 224 (9.0) | 61 (53.5) | <0.0001 |
| At least two comorbidities, n (%) | 30 (1.2) | 18 (0.7) | 12 (10.5) | <0.0001 |
| Non-communicable disease comorbidities, n (%) | 250 (9.6) | 191 (7.6) | 59 (51.8) | <0.0001 |
| Communicable disease comorbidities, n (%) | 39 (1.5) | 35 (1.4) | 4 (3.5) | 0.069 |
| Diabetes, n (%) | 82 (3.1) | 61 (2.4) | 21 (18.4) | <0.0001 |
| Cardiovascular disease, including hypertension, n (%) | 82 (3.1) | 54 (2.2) | 28 (24.6) | <0.0001 |
| Chronic obstructive lung disease, including asthma, n (%) | 72 (2.8) | 66 (2.6) | 6 (5.3) | 0.094 |
| Chronic liver disease, n (%) | 5 (0.2) | 5 (0.2) | 0 (0.0) | 0.633 |
| Chronic kidney disease, n (%) | 16 (0.6) | 12 (0.5) | 4 (3.5) | <0.0001 |
| Malignancy, n (%) | 9 (0.3) | 5 (0.2) | 4 (3.5) | <0.0001 |
| Surgery/trauma, n (%) | 13 (0.5) | 7 (0.3) | 6 (5.3) | <0.0001 |
| Pregnancy, n (%) | 27 (2.8) | 26 (2.8) | 1 (3.9) | 0.747 |
| Human immunodeficiency virus, n (%) | 24 (0.9) | 20 (0.8) | 4 (3.5) | 0.003 |
| Tuberculosis, n (%) | 8 (0.3) | 8 (0.3) | 0 (0.0) | 0.545 |
| Malaria, n (%) | 9 (0.3) | 8 (0.3) | 1 (0.9) | 0.320 |